ID

11984

Descrição

Efficacy and Safety of Idelalisib in Combination With Obinutuzumab Compared to Chlorambucil in Combination With Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT01980875

Link

https://clinicaltrials.gov/show/NCT01980875

Palavras-chave

  1. 30/08/2015 30/08/2015 -
Titular dos direitos

https://clinicaltrials.gov/show/NCT01980875

Transferido a

30 de agosto de 2015

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Chronic Lymphocytic Leukemia NCT01980875

Eligibility Chronic Lymphocytic Leukemia NCT01980875

Inclusion Criteria
Descrição

Inclusion Criteria

not a candidate for fludarabine therapy based on either:
Descrição

therapy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0087111
1. creatinine clearance < 70 ml/min, or
Descrição

creatinine clearance

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0373595
2. cumulative illness rating scale score > 6, by assessment of the investigator
Descrição

investigator; assessment; score

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0582608
diagnosis of b-cell cll, with diagnosis established according to international workshop on chronic lymphocytic leukemia (iwcll)
Descrição

diagnosis; leukemia; chronic; cll

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0023434
no prior therapy for cll other than corticosteroids for disease complications.
Descrição

corticosteroids; complications; prior therapy; other; disease; cll

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0023434
cll that warrants treatment
Descrição

treatment; cll

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0087111
UMLS CUI [2]
C0023434
presence of measurable lymphadenopathy
Descrição

measurable

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0497156
eastern cooperative oncology group (ecog) performance status of ≤ 2
Descrição

eastern cooperative oncology group (ecog) performance status < 1; eastern cooperative oncology group (ecog) performance status 0-2

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Descrição

Exclusion Criteria

known histological transformation from cll to an aggressive lymphoma (ie, richter transformation)
Descrição

lymphoma; from; cll

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0349631
known presence of myelodysplastic syndrome
Descrição

myelodysplastic syndrome

Tipo de dados

boolean

Alias
UMLS CUI [1]
C3463824
evidence of ongoing systemic bacterial, fungal, or viral infection at the time of randomization
Descrição

randomization; evidence of; infection; systemic; ongoing; viral; time

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0243026
ongoing liver injury
Descrição

ongoing; liver

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0160390
ongoing drug-induced pneumonitis
Descrição

pneumonitis; ongoing; drug

Tipo de dados

boolean

Alias
UMLS CUI [1]
C3714636
ongoing inflammatory bowel disease
Descrição

inflammatory; disease; ongoing

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021390
history of prior allogeneic bone marrow progenitor cell or solid organ transplantation
Descrição

organ transplantation; bone marrow; solid organ

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0029216
UMLS CUI [2]
C0149615
ongoing immunosuppressive therapy other than corticosteroids
Descrição

corticosteroids; other; ongoing; therapy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021079
concurrent participation in another therapeutic clinical trial
Descrição

clinical trial

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0008976
undergone major surgery within 30 days prior to randomization
Descrição

major surgery; randomization

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0679637
known hypersensitivity or intolerance to any of the active substances or excipients in the formulations for idela, obinutuzumab, or chlorambucil
Descrição

hypersensitivity; active substance

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1254351
history of non-infectious pneumonitis
Descrição

pneumonitis; non

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0264376
received last dose of study drug on another therapeutic clinical trial within 30 days prior to randomization
Descrição

clinical trial; randomization; study; dose; last; drug

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0013175

Similar models

Eligibility Chronic Lymphocytic Leukemia NCT01980875

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
therapy
Item
not a candidate for fludarabine therapy based on either:
boolean
C0087111 (UMLS CUI [1])
creatinine clearance
Item
1. creatinine clearance < 70 ml/min, or
boolean
C0373595 (UMLS CUI [1])
investigator; assessment; score
Item
2. cumulative illness rating scale score > 6, by assessment of the investigator
boolean
C0582608 (UMLS CUI [1])
diagnosis; leukemia; chronic; cll
Item
diagnosis of b-cell cll, with diagnosis established according to international workshop on chronic lymphocytic leukemia (iwcll)
boolean
C0023434 (UMLS CUI [1])
corticosteroids; complications; prior therapy; other; disease; cll
Item
no prior therapy for cll other than corticosteroids for disease complications.
boolean
C0023434 (UMLS CUI [1])
treatment; cll
Item
cll that warrants treatment
boolean
C0087111 (UMLS CUI [1])
C0023434 (UMLS CUI [2])
measurable
Item
presence of measurable lymphadenopathy
boolean
C0497156 (UMLS CUI [1])
eastern cooperative oncology group (ecog) performance status < 1; eastern cooperative oncology group (ecog) performance status 0-2
Item
eastern cooperative oncology group (ecog) performance status of ≤ 2
boolean
C1520224 (UMLS CUI [1])
lymphoma; from; cll
Item
known histological transformation from cll to an aggressive lymphoma (ie, richter transformation)
boolean
C0349631 (UMLS CUI [1])
myelodysplastic syndrome
Item
known presence of myelodysplastic syndrome
boolean
C3463824 (UMLS CUI [1])
randomization; evidence of; infection; systemic; ongoing; viral; time
Item
evidence of ongoing systemic bacterial, fungal, or viral infection at the time of randomization
boolean
C0243026 (UMLS CUI [1])
ongoing; liver
Item
ongoing liver injury
boolean
C0160390 (UMLS CUI [1])
pneumonitis; ongoing; drug
Item
ongoing drug-induced pneumonitis
boolean
C3714636 (UMLS CUI [1])
inflammatory; disease; ongoing
Item
ongoing inflammatory bowel disease
boolean
C0021390 (UMLS CUI [1])
organ transplantation; bone marrow; solid organ
Item
history of prior allogeneic bone marrow progenitor cell or solid organ transplantation
boolean
C0029216 (UMLS CUI [1])
C0149615 (UMLS CUI [2])
corticosteroids; other; ongoing; therapy
Item
ongoing immunosuppressive therapy other than corticosteroids
boolean
C0021079 (UMLS CUI [1])
clinical trial
Item
concurrent participation in another therapeutic clinical trial
boolean
C0008976 (UMLS CUI [1])
major surgery; randomization
Item
undergone major surgery within 30 days prior to randomization
boolean
C0679637 (UMLS CUI [1])
hypersensitivity; active substance
Item
known hypersensitivity or intolerance to any of the active substances or excipients in the formulations for idela, obinutuzumab, or chlorambucil
boolean
C0020517 (UMLS CUI [1,1])
C1254351 (UMLS CUI [1,2])
pneumonitis; non
Item
history of non-infectious pneumonitis
boolean
C0264376 (UMLS CUI [1])
clinical trial; randomization; study; dose; last; drug
Item
received last dose of study drug on another therapeutic clinical trial within 30 days prior to randomization
boolean
C0013175 (UMLS CUI [1])

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial